Sanofi joins at least eight other drugmakers that have partially or fully loosened their 340B contract pharmacy restrictions in Missouri.
Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions
Views
Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.